Combination of fluoxetine and cognitive therapy for the treatment of major depression among people with HIV infection: A time-series analysis investigation

Cognitive Therapy and Research

Volumn 22, Issue 1, 1998, Pages 21-46

  Savard, Josée ^a   Laberge, Benoît ^a,b   Gauthier, Janel G ^c   Founder, Jean Pierre ^a   Bouchard, Stéphane ^d   Baril, Jean Guy ^e   Bergeron, Michel G ^a  

^a LAVAL UNIVERSITY   (Canada)

^b Inst de Therapie Cogn de Quebec   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d UNIVERSITÉ DU QUÉBEC EN OUTAOUAIS   (Canada)

^e Clinique Mont Carmel   (Canada)

Author keywords

AIDS; Cognitive therapy; Depression; HIV; Treatment

Indexed keywords

CLONAZEPAM; FLUOXETINE;

ADULT; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT ATTITUDE; PERSONALITY DISORDER; RELAPSE; TREATMENT OUTCOME;

EID: 0031957952     PISSN: 01475916     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018759802082     Document Type: Article

References (104)

1. Altamura, A. C., Montgomery, S. A., & Wernicke, J. F. (1988). The evidence for 20 mg a day of fluoxetine as the optimal dose in the treatment of depression. British Journal of Psychiatry, 153 (Suppl. 3), 109-112.
2. American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (3rd ed). Washington, DC: Author.
3. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders-revised (3rd ed). Washington, DC: Author.
4. American Psychiatric Association. (1993). Practice guideline for major depressive disorder in adults. American Journal of Psychiatry, 150 (Suppl.), 1-26.
5. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
6. Anthony, J. C, LeResche, L., Niaz, U., Von Korif, M. R., & Folstein, M. F. (1982). Limits of the Mini-Mental State as a screening test for dementia and delirium among hospital patients. Psychological Medicine, 72, 397-408.
7. Atkinson, J. H., Grant, I., Kennedy, C. J., Richman, D. D., Spector, S. A., & McCutchan, J. A. (1988). Prevalence of psychiatric disorders among men infected with human immunodeficiency virus: A controlled study. Archives of General Psychiatry, 45, 859-864.
8. Aylard, R. P., Gooding, J. H., McKenna, P. J., & Snaith, R. P. (1987). A validation of three anxiety and depression self-assessment scales. Journal of Psychosomatic Research, 31, 261-268.
9. Bandura, A. (1986). Social foundations of thought and action: A social cognitive theory. Englewood Cliffs, NJ: Prentice-Hall.
10. Barlow, D. H., & Hersen, M. (Eds.). (1984). Single case experimental designs: Strategies for studying behavior change (2nd ed.). New York: Pergamon Press.
11. Beasley, C. M., Bosomworth, J. C., & Wernicke, J. F. (1990). Fluoxetine: Relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression. Psychopharmacology Bulletin, 26, 18-24.
12. Beck, A. T., & Beck, R. W. (1972). Screening depressed patients in family practice: A rapid technique. Postgraduate Medicine, 52, 81-85.
13. Beck, A. T., Freeman, A., and Associates. (1990). Cognitive therapy of personality disorders. New York: Guilford Press.
14. Beck, A. T., Kovacks, M., & Weissman, A. (1979). Assessment of suicidal intention: The Scale of Suicidal Ideation. Journal of Consulting and Clinical Psychology, 47, 343-352.
15. Beck, A. T., Rial, W. Y., & Rickels, K. (1974). Short form of depression inventory: Cross validation. Psychological Reports, 34, 1184-1186.
16. Beck, A. T., Rush, A. J., Shaw, B. F., & Emery, G. (1979). Cognitive therapy of depression. New York: Guilford Press.
17. Beck, A. T., Steer, R. A., & Garbin, M. G. (1988). Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clinical Psychology Review, 8, 77-100.
18. Beck, A. T., Ward, C. E., Mendelson, M., Mock, J. E., & Erbaugh, J. K. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561-571.
19. Bhugra, D., Moorey, S., & Minne, C. (1990). Antidepressant and cognitive behavior therapy for an AIDS patient. American Journal of Psychiatry, 147, 256.
20. Blackburn, I. M., & Davidson, K. (1990). Cognitive therapy: Model and efficacy. In Cognitive therapy for depression and anxiety. Oxford, England: Blackwell Scientific Publications.
21. Blackburn, I. M., Bishop, S., Glen, A. I. M., Whalley, L. J., & Christie, J. E. (1981). The efficacy of cognitive therapy in depression: A treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. British Journal of Psychiatry, 139, 181-189.
22. Borkovec, T. D., & Nau S. D. (1972). Credibility of analogue therapy rationales. Journal of Behavioral Therapy and Experimental Psychiatry, 3, 257-260.
23. Box, G. E. P., & Jenkins, G. M. (1976). Time-series analysis: Forecasting and control-revised edition. Oakland, CA: Holden-Day.
24. Brown, G. R., Rundell, J. R., McManis, S. E., Kendall, S. N., Zachary, R., & Temoshok, L. (1992). Prevalence of psychiatric disorders in early stages of HIV infection. Psychosomatic Medicine, 54, 588-601.
25. Burack, J. H., Barrett, D. C., Stall, R. D., Chesney, M. A., Ekstrand, M. L., & Coates, T. J. (1993). Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. Journal of the American Medical Association, 270, 2568-2573.
26. Centers for Disease Control. (1992). 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report 41 (RR- 17).
27. Cohen-Cole, S. A., Brown, F. W., & McDaniel, J. S. (1993). Assessment of depression and grief reactions in the medically ill. In A. Stoudemire, & B. S. Fogel (Eds.), Psychiatric care of the medical patient. New York: Oxford University Press, pp. 53-69.
28. Cooper, G. L. (1988). The safety of fluoxetine-An update. British Journal of Psychiatry, 153 (Suppl. 3), 77-86.
29. Derogatis, L. R. (1975). The SCL-90-R. Baltimore: Johns Hopkins University, Clinical Psychometrics Research Unit.
30. Dobson, K. S. (1989). A meta-analysis of the efficacy of cognitive therapy for depression. Journal of Consulting and Clinical Psychology, 57, 414-419.
31. Fabre, L. F., & Putman, H. P. (1987). A fixed-dose clinical trial of fluoxetine in outpatients with major depression. Journal of Clinical Psychiatry, 48, 406-408.
32. Folkman, S., Chesney, M., McKusick, L., Ironson, G., Johnson, D. S., & Coates, T. J. (1991). Translating coping theory into an intervention. In J. Eckenrode (Ed.), The social context of coping. New York: Plenum Press, pp. 239-260.
33. Folstein, M. F., Folstein, S. E., & McHugh, P R. (1975). Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
34. Gauthier, J., Morin, C., Thériault, F., & Lawson, J. S. (1982). Adaptation française d'une mesure d'autoévaluation de l'intensité de la dépression [French adaptation of a self-report measure of depression intensity]. Revue Québécoise de Psychologie, 3, 13-27.
35. Glass, G. V., Willson, V. L., & Gottman, J. M. (1974). Design and analysis of time-series experiments. Boulder: Colorado Associated University Press.
36. Gotlib, I. H., & Cane, D. B. (1989). Self-report assessment of depression and anxiety. In P. C. Kendall, & D. Watson (Eds.), Anxiety and depression: Distinctive and overlapping features, (pp. 131-169). San Diego, CA: Academic Press.
37. Gould, J. (1982). A psychometric investigation of the standard and short form Beck Depression Inventory. Psychological Reports, 51, 1167-1170.
38. Hintz, S., Kuck, J., Peterkin, J. J., Volk, D. M., & Zisook, S. (1990). Depression in the context of human immunodeficiency virus infection: Implications for treatment. Journal of Clinical Psychiatry, 57, 497-501.
39. Hollon, S. D., DeRubeis, R. J., Evans, M. D., Wiemer, M. J., Garvey, M. J., Grove, W. M., & Tuason, V. B. (1992). Cognitive therapy and pharmacotherapy for depression: Singly and in combination. Archives of General Psychiatry, 49, 774-781.
40. Hollon, S. D., & Najavits, L. (1988). Review of empirical studies on cognitive therapy. In A. J. Frances & R. E. Hales (Eds.), American Psychiatric Press Review of psychiatry (Vol. 7, pp. 643-666). Washington, DC: American Psychiatric Press.
41. Hollon, S. D., Shelton, R. C., & Davis, D. D. (1993). Cognitive therapy for depression: Conceptual issues and clinical efficacy. Journal of Consulting and Clinical Psychology, 67, 270-275.
42. Hollon, S. D., Shelton, R. C., & Loosen, P. T. (1991). Cognitive therapy and pharmacotherapy for depression. Journal of Consulting and Clinical Psychology, 59, 88-99.
43. Jack, T. M., Walker, V. A., Morley, S. J., Hanks, G. W., & Finlay-Mitls, B. M. (1987). Depression, anxiety and chronic pain. Anaesthesia, 42, 1235-1236.
44. Johnson, J. G., Williams, J. B. W., Rabkin, J. G., Goetz, R. R., & Remien, R. H. (1995). Axis I psychiatric symptoms associated with HIV infection and personality disorder. American Journal of Psychiatry, 152, 55]-554.
45. Jones, R. R., Vaught, R. S., & Weinrott, M. (1977). Time-series analysis in operant research. Journal of Applied Behavior Analysis, 10, 151-166.
46. Judd, F. K., Mijch, A. M., & Cockram, A. (1995). Fluoxetine treatment of depressed patients with HIV infection. Australian and New Zealand Journal of Psychiatry, 29, 433-436.
47. Kasper, S., Höflich, G., Scholl, H.-P., & Möller, H.-J. (1994). Safety and antidepressants efficacy of selective serotonin re-uptake inhibitors. Human Psychopharmacology, 9, 1-12
48. Katon, W., & Sullivan, M. D. (1990). Depression and chronic medical illness. Journal of Clinical Psychiatry, 51 (Suppl. 6), 3-11.
49. Kazdin, A. E. (1982). Single-case research designs: Methods for clinical and applied settings. New York: Oxford University Press.
50. Kazdin, A. E. (1984). Statistical analyses for single-case experimental designs. In D. H. Barlow, & M. Hersen (Eds.), Single case experimental designs: Strategies for studying behavior change (2nd ed.). New York: Pergamon Press.
51. Kelly, J. A., Murphy, D. A., Bahr, R., Kalichman, S. G., Morgan, M. G., Stevenson, Y., Koob, J. J., Brasfield, T. L., & Bernstein, B. M. (1993). Outcome of cognitive-behavioral and support group brief therapies for depressed, HIV-infected persons. American Journal of Psychiatry, 150, 1679-1686.
52. Kelly, J. A., Murphy, D. A., Bahr, G. R., Koob, J. J., Morgan, M. G., Kalichman, S. C., Stevenson, L. Y., Brasfield, T. L., Bernstein, B. M., & St Lawrence, J. S. (1993). Factors associated with severity of depression and high-risk sexual behavior among persons diagnosed with human immunodeficiency virus (HIV) infection. Health Psychology, 12, 215-219.
53. Kenn, C., Wood, H., Kucy, M., Wattis, J., & Cunane, J. (1987). Validation of the Hospital Anxiety and Depression Scale (HADS) in an elderly psychiatric population. International Journal of Geriatric Psychiatry, 2, 189-193.
54. Kratochwill, T. R. (1978). Single-subject research: Strategies for evaluating change. New York: Academic Press.
55. Lader, M. (1988). Fluoxetine efficacy vs comparative drugs: An overview. British Journal of Psychiatry, 153 (Suppl. 3), 51-58.
56. Levine, S., Anderson, D., Bystritsky, A., & Baron, D. (1990). A report of eight HIV seropositive patients with major depression responding to fluoxetine. Journal of Acquired Immune Deficiency Syndromes, 3, 1074-1077.
57. Lyketsos, C. G., Hoover, D. R., Guccione, M., Senterfitt, W., Dew, M. A., Wesch, J., VanRaden, M. J., Treisman, G. J., & Morgenstern, H. (1993). Depressive symptoms as predictors of medical outcomes in HIV infection. Journal of the American Medical Association, 270, 2563-2567.
58. Manning, D. W., Markowitz, J. C., & Frances, A. J. (1992). A review of combined and pharmacotherapy in the treatment of depression. Journal of Psychotherapy Practice and Research, 1, 103-116.
59. Markowitz, J. C., Rabkin, J. G., & Perry, S. W. (1994). Treating depression in HIV-positive patients. AIDS, 8, 403-412.
60. Maruff, P., Wood, S., Currie, J., McArthur-Jackson, C., Malone, V., & Benson, E. (1994). Computer-administered Visual Analogue Mood Scales: Rapid and valid assessment of mood in HIV positive individuals. Psychological Reports, 74, 39-42.
61. Moorey, S., Greer, S., Watson, M., Gorman, C., Rowden, L., Tunmore, R., Robertson, B., & Bliss, J. (1991). The factor structure and factor stability of the Hospital Anxiety and Depression Scale in patients with cancer. British Journal of Psychiatry, 158, 255-259.
62. Murphy, G. E., Simons, A. D., Wetzel, R. D., & Lustman, P J. (1984). Cognitive therapy and pharmacotherapy. Archives of General Psychiatry, 41, 33-41.
63. Nace, E. P., Davis, C. W., & Gaspari, J. P (1991). Axis II comorbidity in substance abusers. American Journal of Psychiatry, 148, 118-120.
64. Nierenberg, A. A. (1992). The medical consequences of the selection of an antidepressant. Journal of Clinical Psychiatry, 53 (Suppl. 9), 19-24.
65. Oldham, J. M., Skodol, A. E., Kellman, H. D., Hyler, S. E., Doidge, N., Rosnick, L., & Gallaher, P. E. (1995). Comorbidity of Axis I and Axis II disorders. American Journal o. Psychiatry, 152, 571-578.
66. Olin, J. T., & Zelinski, E. M. (1991). The 12-month reliability of the Mini-Mental State examination. Psychological Assessment, 3, 427-432.
67. Pace, J., Brown, G. R., Rundell, J. R., Paolucci, S., Drexler, K., & McManis, S. (1990). Prevalence of psychiatric disorders in a mandatory screening program for infection with human immunodeficiency virus: A pilot study. Military Medicine, 155, 76-80.
68. Pava, J. A., Fava, M., & Levenson, J. A. (1994). Integrating cognitive therapy and pharmacotherapy in the treatment and prophylaxis of depression: A novel approach. Psychotherapy Psychosomatic, 67, 211-219.
69. Pepper, C. M., Klein, D. N., Anderson, R. L., Riso, L. P., Crosby Ouimette P., & Lizardi, H. (1995). DSM-III-R axis II comorbidity in dysthymia and major depression. American Journal of Psychiatry, 152, 239-247.
70. Perkins, D. O., Davidson, E. J., Leserman, J., Liao, D., & Evans, D. L. (1993). Personality disorder in patients infected with HIV: A controlled study with implications for clinical care. American Journal of Psychiatry, 150, 309-315.
71. Perkins, D. O., Stern, R. A., Golden, R. N., Murphy, C, Naftolowitz, D., & Evans, D. L. (1994). Mood disorders in HIV infection: Prevalence and risk factors in a nonepicenter of the AIDS epidemic. American Journal of Psychiatry, 757, 233-236.
72. Perry, S., Fishman, B., Jacobsberg, L., & Frances, A. (1992), Relationship over 1 year between lymphocyte subsets and psychosocial variables among adults with infection by human immunodeficiency virus. Archives of General Psychiatry, 49, 396-401.
73. Ponterotto, J. G., Pace, T. M., & Kavan, M. G. (1989). A counselor's guide to the assessment of depression. Journal of Counseling and Development, 67, 301-309.
74. Preskorn, S. H., & Burke, M. (1992). Somatic therapy for major depressive disorder: Selection of an antidepressant. Journal of Clinical Psychiatry, 53 (Suppl. 9), 5-18.
75. Quitkin, F. M. (1992). Methodology of measuring the efficacy of antidepressants. Psychopharmacology, 106, S87-S89.
76. Quitkin, F. M., Rabkin, J. G., Ross, D., & McGrath, P. J. (1984). Duration of antidepressant treatment. Archives of General Psychiatry, 41, 238-245.
77. Rabkin, J. G., & Harrison, W M. (1990). Effect of imipramine on depression and immune status in a sample of men with HIV infection. American Journal of Psychiatry, 147, 495-497.
78. Rabkin, J. G., & Klein, D. F. (1987). The clinical measurement of depressive disorders. In A. J. Marsella, R. M. A. Hirschfeld, & M. M. Matz (Eds.), The measurement of depression (pp. 30-83). New York: Guilford Press.
79. Rabkin, J. G., Rabkin, R., Harrison, W., & Wagner, G. (1994). Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness. American Journal of Psychiatry, 757, 516-523.
80. Rabkin, J. G., Rabkin, R., & Wagner, G. (1994). Effects of fluoxetine on mood and immune status in depressed patients with HIV illness. Journal of Clinical Psychiatry, 55, 92-97.
81. Rabkin, J. G., Williams, J. B., Remien, R. H., Goetz, R., Kertzner, R., & Gorman, J. M. (199]). Depression, distress, lymphocyte subsets, and human immunodeficiency virus symptoms on two occasions in HIV-positive homosexual men. Archives of General Psychiatry, 48, 111-119.
82. Radloff, L. S. (1977). The CES-D Scale: A new self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
83. Reich, J. H., & Green, A. I. (1991). Effect of personality disorders on outcome of treatment. The Journal of Nervous and Mental Disease, 179, 74-82.
84. Reich, J. H., & Vasile, R. G. (1993). Effect of personality disorders on the treatment outcome of axis I conditions: An update. The Journal of Nervous and Mental Disease, 181, 475-484.
85. Reynolds, W. M., & Gould, J. W. (1981). A psychometric investigation of the Standard and Short Form Beck Depression Inventory. Journal of Consulting and Clinical Psychology, 49, 306-307.
86. Rosenberger, P. H., Bornstein, R. A., Nasrallah, H. A., Para, M. F., Whitaker, C. C., Pass, R. J., & Rice, R. R. (1993). Psychopathology in human immunodeficiency virus infection: Lifetime and current assessment. Comprehensive Psychiatry, 34, 150-158.
87. Rush, A. J. (1983). Cognitive therapy of depression: Rationale, techniques and efficacy. Psychiatric Clinics of North America, 6, 105-127.
88. Sahs, J. A, Goetz, R., Reddy, M., Rabkin, J. G., Williams, J. B. W., Kertzner, R., & Gorman, J. M. (1994). Psychological distress and natural killer cells in gay men with and without HIV infection. American Journal of Psychiatry, 151, 1479-1484.
89. Savard, J., Laberge, B., Gauthier, J. G., & Bergeron, M. G. (1996). Empirical validation of the Hospital Anxiety and Depression scale in HIV-Infected patients Submitted Publication.
90. Schatzberg, A. F. (1991). Dosing strategies for antidepressant agents. Journal of Clinical Psychiatry, 52 (Suppl.), 14-20.
91. Schwarz, G, (1978). Estimating the dimension of a model. Annals of Statistics, 6, 461-464.
92. Schweizer, E., Rickeis, K., Amsterdam, J. D., Fox, I., Puzzuoli, G., & Weise, C. (1990). What constitutes an adequate antidepressant trial for fluoxetine. Journal of Clinical Psychiatry, 57, 8-11.
93. Sensky, T, Dennehy, M., Gilbert, A., Begent, R., Newlands, E., Rustin, G., & Thompson, C. (1989). Physicians' perceptions of anxiety and depression among their outpatients: Relationships with patients and doctors' satisfaction with their interviews. Journal of the Royal College of Physicians of London, 23, 33-38.
94. Shea, M. T, Elkin, I., Imber, S. D., Sotsky, S. M., Watkins, J. T., Col]ins, J. E, Pilkonis, P. A., Beckham, E., Glass, D. R., Dolan, R. T., & Par]off, M. B. (1992). Course of depressive symptoms over follow-up: Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Archives of General Psychiatry, 49, 782-787.
95. Shea, M. T, Pilkonis, P. A., Beckham, E., Collins, J. F., E]kin, L., Sotsky, S. M., & Docherty, J. P. (1990). Personality disorders and treatment outcome in the NIMH treatment of depression collaborative research program. American Journal of Psychiatry, 147, 711-718.
96. Shea, M. T., Widiger, T. A., & Klein, M. H. (1992). Comorbidity of personality disorders and depression; Implications for treatment. Journal of Consulting and Clinical Psychology, 60, 857-868.
97. Spitzer, R. L., Williams, J. B. W., Gibbon, M., & First, M. B. (1990a). Structured Clinical Interview for DSM-III-R - patient edition (SCID-P, Version 1.0). Washington, DC: American Psychiatric Press.
98. Spitzer, R. L., Williams, J. B. W., Gibbon, M., & First, M. B. (1990b). Structured Clinical Interview for DSM-111-R - personality disorders (SCID-II, Version 1.0). Washington, DC: American Psychiatric Press.
99. Stoudemire, A. (1995). Expanding psychopharmacologic treatment options for the depressed medical patient. Psychosomatics, 36, S19-S26.
100. Thase, M. E. (1990). Relapse and recurrence in unipolar major depression: Short-term and long-term approaches. Journal of Clinical Psychiatry, 51 (Suppl. 6), 51-57.
101. Thase M. E. (1992). Long-term treatments of recurrent depressive disorders. Journal of Clinical Psychiatry, 53 (Suppl. 9), 32-44.
102. Usher, R. W., Beasley, C. M., & Bosomworth, J. C. (1991). Efficacy and safety of morning versus evening fluoxetine administration. Journal of Clinical Psychiatry, 52, 134-136.
103. Williams, J. B. W., Rabkin, J. G., Remien, R. H., Gorman, J. M., & Ehrhardt, A. A. (1991). Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. II. Standardized clinical assessment of current and lifetime psychopathology. Archives of General Psychiatry, 48, 124-130.
104. Zigmond, A. S., & Snaith, R. P. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67, 361-370.